Form 4: Eli Lilly Executive Transfers 14,700 Shares to Spousal Trust

An Eli Lilly executive, Anat Hakim, transferred 14,700 shares of company stock to a spousal lifetime access trust on August 12, 2024.

Summary

• Anat Hakim, an Executive Vice President, General Counsel, and Secretary at Eli Lilly & Co, reported a transaction on August 12, 2024.
• Ms. Hakim transferred 14,700 shares of Eli Lilly common stock to a spousal lifetime access trust.
• The trust's trustee is Ms. Hakim's spouse, and the beneficiaries are her spouse and children.
• Ms. Hakim disclaims beneficial ownership of these shares except for her pecuniary interest.
• The transfer was not a sale, and the price is listed as $0 for the transaction.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing regarding an executive's stock transfer, which is neither positive nor negative for the company's performance.

Management Comments

• Anat Hakim disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein.

Industry Context

This is a routine filing related to executive stock transactions and is common practice for executives managing their personal finances and estate planning.

Comparison to Industry Standards

• Executive stock transfers to trusts are a common practice among publicly traded companies.
• These transactions are typically disclosed via SEC Form 4 filings, as seen in this case.
• Similar transactions are often seen with executives at companies like Pfizer, Merck, and AbbVie.

Related Party Transactions

• The transfer of shares to a spousal lifetime access trust is a related party transaction.

Stakeholder Impact

• The transaction has minimal impact on shareholders as it is a transfer of ownership, not a sale.
• The transaction does not directly impact employees, customers, suppliers, or creditors.

Key Dates

Keywords

Eli Lilly, Anat Hakim, stock transfer, spousal trust, beneficial ownership, SEC Form 4, executive transaction